What works for Whom in Pediatric OCD
What works for Whom in Pediatric OCD
批准号:
10665713
负责人:
DAVID Heaton BARKER
金额:
$34.69万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-15 至 2025-06-30
关键词:
AddressAgeAppleBehavior TherapyCaregiversCharacteristicsChildChildhoodClinicalClinical DataClinical TrialsCognitiveCognitive TherapyDataDevelopmentDoseEducationEmotionalEvaluationEvidence based interventionFamilyFamily psychotherapyFoundationsHeadHospitalsIndividualInfrastructureInternationalInterventionLeadershipLengthMeasuresMeta-AnalysisMethodsModalityModificationNational Institute of Mental HealthObsessive-Compulsive DisorderOutcomeParticipantPatient advocacyPatient-Focused OutcomesPatientsPopulationPreventionPrincipal InvestigatorProcessRecording of previous eventsRelaxationResearchSample SizeSamplingScheduleSeveritiesSeverity of illnessStatistical ModelsSubgroupSymptomsTarget PopulationsTestingTimeTransportationTreatment EffectivenessTreatment EfficacyVariantWorkanalytical toolburden of illnesscomorbiditycomparative effectivenesscompare effectivenesscomparison interventiondata archiveethnic minority populationimprovedinsightmemberoutpatient programspatient subsetsprogramsracial minority populationrandomized trialreduce symptomsresponsesocialtherapy outcometreatment comparisontreatment responseusability
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Improving patient outcomes will be enhanced by understanding “what works, for whom?” enabling better
matching of patients to available treatments. Despite a wealth of research seeking to optimize CBT outcomes
for pediatric obsessive-compulsive disorder (OCD), we have limited understanding about how to match
patients with the appropriate treatment package. Past research has identified patient characteristics that may
influence treatment response, including age, symptom severity, comorbidities, and previous treatment history.
Unfortunately, findings have been inconsistent due to limited sample size, a focus on one modifier at a
time, and difficulty integrating results across trials with different sample characteristics. Between-trial
differences in sample characteristics severely limit conventional meta-analytic tools, greatly complicating
cross-trial comparisons of treatment efficacy. This project will use individual-participant-data from 27 trials and
data from two clinical populations and utilize recent advancements in transportability methods facilitates
understanding “what works, for whom?” Transportability methods include causal analytic approaches to
extend inferences from trial samples to target populations when there are marked differences in the distribution
of sample characteristics between trials and the target population. Robust statistical models are used
to address between-trial differences in covariates, enabling the transportation of causal estimates from trial
samples to target populations. Under explicit causal and statistical assumptions, the transported analyses
provide unbiased estimates of how interventions will fair in the target population(s), enabling apples-to-apples
comparisons of interventions even when two interventions have not been compared in a head-to-head trial. In
addition, the target population can be defined as sub-populations (e.g., younger children with high illness
severity, comorbidities), enabling evaluation of relevant interventions for that sub-population, effectively
providing insight into the question of “what works for whom?”
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sleep and Circadian Methods (SCM) Core
-
批准号:10594995
-
项目类别:
-
资助金额:$48.51万
-
财政年份:2021
-
负责人:DAVID Heaton BARKER
-
依托单位:
Sleep and Circadian Methods (SCM) Core
-
批准号:10385697
-
项目类别:
-
资助金额:$48.99万
-
财政年份:2021
-
负责人:DAVID Heaton BARKER
-
依托单位:
Sleep and Circadian Methods (SCM) Core
-
批准号:10090149
-
项目类别:
-
资助金额:$31.47万
-
财政年份:2021
-
负责人:DAVID Heaton BARKER
-
依托单位:
Comparative Efficacy of HIV-Prevention among Youth with Mental Health Needs
-
批准号:9026651
-
项目类别:
-
资助金额:$16.96万
-
财政年份:2014
-
负责人:DAVID Heaton BARKER
-
依托单位:
Comparative Efficacy of HIV-Prevention among Youth with Mental Health Needs
-
批准号:8727174
-
项目类别:
-
资助金额:$16.92万
-
财政年份:2014
-
负责人:DAVID Heaton BARKER
-
依托单位:
Comparative Efficacy of HIV-Prevention among Youth with Mental Health Needs
-
批准号:8848142
-
项目类别:
-
资助金额:$16.95万
-
财政年份:2014
-
负责人:DAVID Heaton BARKER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: